Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the global population. Despite an array of treatment modalities, depressive disorders remain difficult to manage due to many factors. Beginning with the introduction of fluoxetine to the United States in 1988, sele...
Saved in:
Main Authors: | Amber N. Edinoff (Author), Haseeb A. Akuly (Author), Tony A. Hanna (Author), Carolina O. Ochoa (Author), Shelby J. Patti (Author), Yahya A. Ghaffar (Author), Alan D. Kaye (Author), Omar Viswanath (Author), Ivan Urits (Author), Andrea G. Boyer (Author), Elyse M. Cornett (Author), Adam M. Kaye (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations
by: Amber N. Edinoff, et al.
Published: (2021) -
Aripiprazole Lauroxil, a Novel Injectable Long-Acting Antipsychotic Treatment for Adults with Schizophrenia: A Comprehensive Review
by: Kunal Maini, et al.
Published: (2021) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002) -
VALTOCO<sup>®</sup> (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity
by: Elyse M. Cornett, et al.
Published: (2021)